Contact UsCareersMediaScienceContact UsHomeOur Voice Pfizer announces recipients of research grants focused on transthyretin amyloid cardiomyopathy inHomeOur VoiceWednesday, November 20, 2024In recognition of National Child Day, Pfizer Canada is proud to highlight the organization's global efforts to help protect children from pneumonia, the leading infectious cause of mortality in children under five years old1.
Pfizer recently announced that it has delivered one billion doses of its pneumococcal vaccine as part of its collaboration with Gavi, the Vaccine Alliance. Pfizer’s collaboration with Gavi is part of the company’s broader commitment to help address health equity gaps around the world and enable accelerated access to medicines and vaccines.
Earlier this fall, the billionth dose was delivered to Ethiopia for its national vaccination program for children against pneumococcal disease. "Gavi’s success in immunizing over a billion children since 2000 is built upon its unique multistakeholder model. Vaccine manufacturers play a critical role in this partnership, helping us build healthy, affordable markets for vaccines and delivering innovative new solutions.” said Dr. Sania Nishtar, CEO, Gavi, the Vaccine Alliance. "We are proud of reaching this important milestone together with Pfizer and look forward to impactful collaboration in the future.”
In Ethiopia, more than 40,000 children under five die each year from pneumonia2, a major cause of post-neonatal mortality. It is a leading cause of death during the postnatal period, accounting for 20% of deaths in this age group every year3. Since 2020, Pfizer has supplied more than 40 million pneumococcal vaccines to support the country’s vaccination efforts.As the world celebrates National Child Day, Pfizer Canada remains dedicated to collaborating with global partners to expand access to essential medicines and vaccines, and to support initiatives that improve the health and well-being of children everywhere.
Beyond our global partnership with Gavi, Pfizer Canada is committed to working with partners to address health inequities and improve access to essential medicines and vaccines for vulnerable populations outside of this country. "We are proud to support global initiatives, which align with Pfizer Canada's own commitment to improving access to essential medicines for vulnerable populations," said An Van Gerven, President of Pfizer Canada.
For example, in 2024 so far, Pfizer Canada has donated over $1.5 million worth of essential medicines through its partnership with Health Partners International Canada (HPIC), an aid organization that distributes donated medicines and medical products for humanitarian missions in vulnerable communities that are challenged by accessing quality health. This support helps ensure that children and families in low-resource settings have access to the treatments they need.
"Our partnership with HPIC is a testament to Pfizer Canada's dedication to global health equity," said Vincent Lamoureux, Director of Global Health and Social Impact at Pfizer Canada. "In addition to our product donations, our colleagues have volunteered their time at HPIC to pack and prepare essential medicines for distribution to those in need around the world. National Child Day is a powerful reminder of the importance of this work and our commitment to making a positive impact on the lives of children everywhere."
____
3Leka Lutpiatina, Lilis Sulistyorini, Ririh Yudhastuti, Hari Basuki Notobroto, Prediction of Toddlers Acute Respiratory Infection (ARI) to Become Pneumonia in Martapura Catchment Area, Banjar District, Indonesia, Global Pediatric Health, 10.1177/2333794X241227694, 11, (2024). Available at: https://pubmed.ncbi.nlm.nih.gov/38405016/
Our Voice
It’s National Immunization Awareness Month. Here Are Some Tips To Help
Separate Fact From Fiction.
Where Compassion Leads: Patricia’s Lifelong Commitment to Community
Finding Joy on the Road: Curtis’s Journey with the Friends for Life Bike Rally
Pfizer Supports Indigenous Pharmacy Student's Pursuit of Culturally-Informed Care
Unlocking the Full Potential of Innovation in Canada: A Pathway to Healthier Lives and Stronger Communities
Pfizer Canada's Clinical Trials: Advancing Medical Innovation and Improving Patient Outcomes
Pfizer Canada Leads the Way in Advancing Inflammatory Bowel Disease Care
Wishing Love and Health to all Mothers
The value of vaccines in protecting our health and well-being
Reframing Cancer as Part of the Story
This World Health Day: Protecting Infants through Maternal Vaccination
Pfizer Canada Proud to Support Innovative Mobile Health Clinic for Vulnerable Children in Montreal
Pfizer's Medical Affairs Team: Advancing Science and Improving Patient Care
Introducing the Faces of Pfizer Fighting Against Cancer in Canada
Empowering Growth at Pfizer Canada: The Transformative Impact of Group Mentorship
Advancing Cancer Care in Canada Through Collaborative Innovation
Giving A Hand at the Paralympics - A Volunteer Story
Exploring the Future of Canada’s Digital Health with Pfizer’s First Healthcare Hub Winners
World Pneumonia Day: Supporting Vaccination Efforts Across Canada
Empowering Early Breast Cancer Detection through Innovation
Meet Jacquie Baker, Recipient of the CCS-Pfizer ATTR-CM 2023 Research Fellowship Award
Culturally Responsive Health Care: Wellness Wheel Clinical Team and their Approach to Care with First Nations Communities
Caring for Aging Parents with Compassion and Wisdom
Pfizer’s Commitment to Indigenous Health Research
Celebrating World Pharmacist Day: How PharmaGuide Empowers Pharmacists to Help Enhance Patient Care in Canada
Counterfeit Medicines: A Serious Threat to Patient Safety
Paralympic Hopeful Allison Lang Shares Her Story of Disability Advocacy and Excellence in Sport
The importance of data this National Immunization Awareness Month